Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2025 06:05 ET | Source: Research and Markets

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Pipeline Market Research 2025 | Key Players Include Intellia Therapeutics, Renowned for NTLA-2001 in Phase III Development, Leveraging CRISPR/Cas9

Dublin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The "Transthyretin Amyloid Cardiomyopathy (ATTR-CM) - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report answers...
July 28, 2025 08:00 ET | Source: NetraMark Holdings Inc.

NetraMark Signs Contract with AlgoTx to Enhance Clinical Trial Design for ATX01

TORONTO, July 28, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company...
June 06, 2025 10:17 ET | Source: Research and Markets

Peripheral Neuropathy Treatment Market Landscape 2025-2029: Robust Drug Pipeline to Expand the Market by $481 Million

Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Treatment Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The global peripheral neuropathy treatment...
June 04, 2025 09:07 ET | Source: Research and Markets

Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast Report 2025 | Profiling Key Innovators in CIPN Therapeutics

Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Market by Treatment Type, Route of Administration, Patient Age Group, Therapy Duration, End-User -...
May 07, 2025 04:06 ET | Source: Research and Markets

Diabetic Peripheral Neuropathy Market Report 2025-2035 - Pharmacological and Non-Pharmacological Innovations Expand Treatment Landscape for Diabetic Neuropathy

Dublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "Diabetic Peripheral Neuropathy Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has...
April 23, 2025 17:24 ET | Source: Azura Virtal Balance

Nerve Recovery Max Under Review: Ingredients to Support Healthy Nerve Wellness

New York City, April 23, 2025 (GLOBE NEWSWIRE) -- For many people, nerve discomfort doesn’t begin with a loud warning. It starts small, a strange tingling in the toes, a mild burning in the hands,...
April 22, 2025 16:20 ET | Source: Nerve Alive

Nerve Alive Under Review: Best Nerve Supplement for Neuropathy with Carefully Selected Natural Ingredients

New York City, April 22, 2025 (GLOBE NEWSWIRE) -- Introduction What Is Neuropathy? Neuropathy, often referred to as peripheral neuropathy, is a condition that arises when the nerves outside of...
March 24, 2025 11:32 ET | Source: Research and Markets

Diabetic Neuropathic Pain Analysis Report 2025: Global Market Set for Growth, Reaching $8.5 Billion by 2032 Featuring Pfizer, NeuroMetrix, GSK, Johnson & Johnson, and Lupin

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Diabetic Neuropathic Pain Market" report has been added to ResearchAndMarkets.com's offering. Diabetic neuropathic pain market is projected to...
September 26, 2024 12:06 ET | Source: Transparency Market Research

Diabetic Neuropathy Market Size Set to Hit USD 8.5 Billion by 2034 with a 5.5% CAGR, Boosted by Biomarker-based Diagnostics and Stem Cell Therapy – Analysis by Transparency Market Research

Wilmington, Delaware, United States, Transparency Market Research, Inc., Sept. 26, 2024 (GLOBE NEWSWIRE) -- The diabetic neuropathy market (سوق الاعتلال العصبي السكري) was worth US$ 4.6 billion in...
July 11, 2024 12:52 ET | Source: SNS Insider pvt ltd

Peripheral Neuropathy Market Size to Surpass US$ 2.38 Billion By 2032, Driven by Rising Diabetes and Nerve Damage Cases | Research by SNS Insider

Pune, July 11, 2024 (GLOBE NEWSWIRE) -- Peripheral Neuropathy Market Analysis: “The Peripheral Neuropathy Market size was valued at US$ 1.48 billion in 2023, estimated to reach US$ 2.38 billion...